Reid I A, Moffat B
Endocrinology. 1978 Oct;103(4):1494-8. doi: 10.1210/endo-103-4-1494.
To determine if the brain enzyme which has renin-like activity in vitro can form angiotensin in vivo, angiotensin II concentration in cerebrospinal fluid (CSF) was measured before and at various intervals after injection of partially purified renin substrate (angiotensinogen) into the third cerebral ventricle of anesthetized dogs. The injection increased CSF angiotensinogen concentration 3-fold, but despite this, CSF angiotensin II concentration, which was undetectable (less than 6.25 fmol/ml) before injection, did not change. Arterial blood pressure was also unchanged after the injection. In contrast, both CSF angiotensin II concentration and arterial pressure increased after an inventricular injection of renin. These results demonstrate that angiotensin II is formed centrally after administration of exogenous renin but not after injection of angiotensinogen. The results thus fail to demonstrate renin activity in the brain in vivo.
为了确定在体外具有肾素样活性的脑酶能否在体内形成血管紧张素,在麻醉犬的第三脑室注射部分纯化的肾素底物(血管紧张素原)之前及之后的不同时间间隔,测量脑脊液(CSF)中血管紧张素II的浓度。注射使CSF血管紧张素原浓度增加了3倍,但尽管如此,注射前无法检测到(低于6.25 fmol/ml)的CSF血管紧张素II浓度并未改变。注射后动脉血压也未改变。相比之下,脑室内注射肾素后,CSF血管紧张素II浓度和动脉血压均升高。这些结果表明,外源性肾素给药后血管紧张素II在中枢形成,但注射血管紧张素原后则不然。因此,这些结果未能证明体内脑中有肾素活性。